ATRA vs BEN · rev $128.9M vs P/E 36, rev $8.77B
Atara Biotherapeutics Inc (ATRA) versus Franklin Resources Inc (BEN) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
ATRA currently screens at market cap $87.1M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Not investment advice. Open the ATRA and BEN stock pages for the full models.
Not investment advice.